IDiyas

For the Inventor, By the Inventor

Belmont, MA, United States of America

Oleg Epstein

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 10.3

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:

goldMedal10 out of 1,970 
 
Amgen Inc.
 patents
silverMedal1 out of 124 
 
Teijin Pharma Limited
 patents
where one patent can have more than one assignee

Years Active: 2013-2017

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):
1. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-10-03),
2. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-08-08),
3. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),
4. 9365522 - Pyrazole amide derivative (2016-06-14),
5. 9309263 - Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof (2016-04-12),
6. 9296759 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2016-03-29),
7. 8962859 - Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use (2015-02-24),
8. 8957083 - Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use (2015-02-17),
9. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use (2014-11-11),
10. 8426447 - Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use (2013-04-23),

Title: The Innovative Contributions of Oleg Epstein

Introduction

Oleg Epstein, based in Belmont, MA, is a prominent inventor known for his significant contributions to the field of pharmaceutical compounds. With a portfolio of 10 patents, his work primarily focuses on modulating enzyme activity related to neurological disorders.

Latest Patents

Among his latest innovations are the amino-oxazine and amino-dihydrothiazine compounds, described as beta-secretase modulators. These compounds have shown potential in treating beta-secretase mediated diseases, including Alzheimer's disease and various cognitive impairments. The patents encompass detailed compositions and methods for pharmaceutical applications targeting disorders caused by beta-secretase protein activity. The formulations propose a new class of compounds designed to aid in the treatment, prophylactic or therapeutic, of conditions associated with plaque formation in the brain.

Career Highlights

Oleg Epstein has built a robust career, which includes tenure at leading companies such as Amgen Inc. and Teijin Pharma Limited. His experience in these esteemed organizations has provided him with the opportunity to refine his innovative approaches in biotechnology and pharmaceutical research.

Collaborations

Throughout his career, Epstein has collaborated with distinguished professionals, including Ryan D. White and Jason Brooks Human. These partnerships have likely enhanced his ability to develop groundbreaking therapeutic solutions effectively.

Conclusion

Oleg Epstein’s contributions to science and technology, particularly in the realm of neuropharmacology, reflect his dedication to addressing pressing health challenges. His innovative patents provide promising avenues for treating complex diseases such as Alzheimer’s, underscoring the critical impact of his work in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…